The Financial Burden of Patient Comorbidities on Total Knee Arthroplasty Procedures: A Matched Cohort Analysis of Patients Who Have a High and Non-High Comorbidity Burden
The Journal of Arthroplasty · 2025
DOI: 10.1016/j.arth.2024.11.059 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Arthroplasty, 2025. Verfasst von Jonathan L Katzman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, NYU Langone Health, New York, New York. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Knee, Cost of Illness, Osteoarthritis, Knee. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Recent literature suggests a trend toward a higher comorbidity burden in patients undergoing total knee arthroplasty (TKA). However, the impact of increased comorbidities on the cost-effectiveness of TKA is underexplored. This study aimed to compare the financial implications and perioperative outcomes of patients with and without a high comorbidity burden (HCB). METHODS: We retrospectively reviewed 10,647 patients who underwent elective, unilateral TKA between 2012 and 2021 at a single academic health center with available financial data. Patients were stratified into HCB (Charlson Comorbidity Index ≥ 5 and American Society of Anesthesiology scores of 3 or 4) and non-HCB groups. A 1:1 propensity match was performed based on baseline characteristics, resulting in 1,536 matched patients (768 per group). Revenue, costs, and contribution margins (CM) of the inpatient episode were compared between groups. Ninety-day readmissions and revisions were also analyzed. RESULTS: The HCB patients had significantly higher total (P < 0.001) and direct (P < 0.001) costs, while hospital revenue did not differ between cohorts (P = 0.638). This disparity resulted in a significantly decreased CM for the HCB group (P = 0.009). Additionally, HCB patients had a longer length of stay (P < 0.001) and a higher rate of 90-day readmissions (P = 0.005). CONCLUSIONS: Increased inpatient costs for HCB patients undergoing TKA were not offset by proportional revenue, leading to a decreased CM. Furthermore, higher 90-day readmissions exacerbate the financial burden. These findings highlight potential challenges for hospitals in covering indirect expenses, which could jeopardize accessibility to care for HCB patients. Reimbursement models should be revised to better account for the increased financial burden associated with managing HCB patients. LEVEL OF EVIDENCE: III.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, NYU Langone Health, New York, New York.
- Department of Orthopedic Surgery, NYU Langone Health, New York, New York; Division of Orthopaedic Surgery, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Zitieren
APA
Katzman, J. L., Thomas, J., Ashkenazi, I., Lajam, C. M., Rozell, J. C., & Schwarzkopf, R. (2025). The Financial Burden of Patient Comorbidities on Total Knee Arthroplasty Procedures: A Matched Cohort Analysis of Patients Who Have a High and Non-High Comorbidity Burden. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2024.11.059
Vancouver
Katzman JL, Thomas J, Ashkenazi I, Lajam CM, Rozell JC, Schwarzkopf R. The Financial Burden of Patient Comorbidities on Total Knee Arthroplasty Procedures: A Matched Cohort Analysis of Patients Who Have a High and Non-High Comorbidity Burden. The Journal of Arthroplasty. 2025. doi:10.1016/j.arth.2024.11.059
BibTeX
@article{Katzman2025,
author = {Katzman, Jonathan L and Thomas, Jeremiah and Ashkenazi, Itay and Lajam, Claudette M and Rozell, Joshua C and Schwarzkopf, Ran},
title = {The Financial Burden of Patient Comorbidities on Total Knee Arthroplasty Procedures: A Matched Cohort Analysis of Patients Who Have a High and Non-High Comorbidity Burden},
journal = {The Journal of Arthroplasty},
year = {2025},
doi = {10.1016/j.arth.2024.11.059}
}
EUVIMED